Dağdelen Sinan
Department of Cardiology, Acibadem Kadiköy Hospital, Istanbul, Turkey.
Turk Kardiyol Dern Ars. 2009 Mar;37(2):125-7.
Central venous thrombosis is an important complication of venous catheterization. We presented a 49-year-old male patient who developed massive central venous thrombosis causing superior vena cava (SVC) syndrome after placement of a right subclavian vein port catheter. The patient had inoperable gastric cancer for which he had been receiving chemotherapy for two years. He had a six-month history of fixed port catheter placement into the right subclavian vein. Contrast-enhanced computed tomography (CT) of the chest showed complete obstruction of the SVC and CT angiography showed extensive thrombosis from the subclavian vein to the end of the SVC. Extensive lung and mediastinal metastases were also observed. Surgical intervention was not considered. Fibrinolytic therapy was instituted with 75 mg tissue plasminogen activator (tPA) infusion for 18 hours. The patient's symptoms and the signs of SVC syndrome disappeared and clinical parameters returned to normal within several hours. The day after completion of fibrinolytic therapy, repeat contrast CT angiography showed total resolution of SVC thrombosis. Slow infusion of tPA may be effective in the treatment of SVC syndrome caused by acute thrombosis.
中心静脉血栓形成是静脉置管的一种重要并发症。我们报告了一名49岁男性患者,其在右锁骨下静脉置入端口导管后发生大量中心静脉血栓形成,导致上腔静脉(SVC)综合征。该患者患有无法手术的胃癌,已接受两年化疗。他有右锁骨下静脉置入固定端口导管6个月的病史。胸部增强计算机断层扫描(CT)显示SVC完全阻塞,CT血管造影显示从锁骨下静脉到SVC末端广泛血栓形成。还观察到广泛的肺和纵隔转移。未考虑手术干预。采用75mg组织纤溶酶原激活剂(tPA)输注18小时进行纤溶治疗。患者的症状和SVC综合征体征消失,临床参数在数小时内恢复正常。纤溶治疗完成后的第二天,重复对比CT血管造影显示SVC血栓完全溶解。缓慢输注tPA可能对治疗急性血栓形成引起的SVC综合征有效。